For the Inventor, By the Inventor

Enter inventor name

Henrik Clausen

USPTO Granted Patents = 52 (Patent Applications = 9)

EPO Patents = 7 (Patent Applications = 6)

Average Co-Inventor Count = 3.0

ph-index = 10

Forward Citations = 320(Granted Patents)

Forward Citations (Not Self Cited) = 270(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Hoite, DK (2008)
Holte, DE (2008)
2840 Holte, DK (2010)
Copenhagen, DK (2015 - 2023)
Holte, DK (1994 - 2024)

Company Filing History:

Velico Medical, Inc.

Cancer Research Technology Limited

Københavns Universitet

University of Copenhagen

Go Therapeutics, Inc.

7. 3 out of 1,777

Novo Nordisk A/s

Glycodisplay Aps

9. 2 out of 228

Danmarks Tekniske Universitet

10. 1 out of 50

Neose Technologies, Inc.

12. 1 out of 37

The Biomembrane Institute

13. 1 out of 1,370

The Brigham and Women's Hospital, Inc.

14. 1 out of 17

Zymequest, Inc.

Bay Development Corporation Sa

Kobenhavns Univerrsitet

Beverly Spv1, LLC

Glycozym USA Inc.

20. 4 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2025

Loading Chart...

Loading Chart...

52 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12325871 - Lysosomal enzymes modified by cell based glycoengineering (2025-06-10),

2. 11860165 - CORE3-MUC1 binding polypeptides and uses thereof (2024-01-02),

3. 11708569 - Modified recombinant lysosomal alpha-galactosidase A and aspartylglucoaminidase having low mannose-6-phosphate and high sialic acid (2023-07-25),

4. 11067578 - Tn-MUC4 binding polypeptides and uses thereof (2021-07-20),

5. 10919973 - Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies (2021-02-16),

6. 10889845 - Production of N-glycoproteins for enzyme assisted glycomodification (2021-01-12),

7. 10858671 - N-glycosylation (2020-12-08),

8. 10139414 - Tn-MUC4 binding polypeptides and uses thereof (2018-11-27),

9. 10017576 - Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies (2018-07-10),

10. 9588121 - Method for early detection of cancer (2017-03-07),

11. 9359436 - Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies (2016-06-07),

12. 9034626 - Methods of preparing tissues for xenotransplantation using alpha-galactosidases (2015-05-19),

13. 9029331 - Glycopegylated granulocyte colony stimulating factor (2015-05-12),

14. 9024110 - Methods for glyco-engineering plant cells for controlled human O-glycosylation (2015-05-05),

15. 8912311 - Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies (2014-12-16),

Title: Henrik Clausen - Innovative Inventor from Holte, Denmark

Introduction: Henrik Clausen is a renowned inventor hailing from Holte, Denmark, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Henrik Clausen holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With a career spanning over two decades, Henrik Clausen has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Henrik Clausen has collaborated with top companies, innovative startups, and talented individuals to bring his ideas to life and make a lasting impact on the world of innovation.

Conclusion: Henrik Clausen's passion for pushing the boundaries of what is possible, combined with his dedication to creating a more sustainable and technologically advanced future, solidifies his position as a visionary inventor shaping the world of tomorrow.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…